BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 10, 2003
View Archived Issues
FDA Panel Comes Out In Favor Of Raptiva From Genentech, XOMA
An FDA panel of experts voted in favor of Raptiva, a humanized monoclonal antibody made by Genentech Inc. and XOMA Ltd. for the treatment of moderate to severe plaque psoriasis in adults. (BioWorld Today)
Read More
Amgen Files Cinacalcet NDA; Drug Targets Dialysis Patients
Read More
Chinese Civet Cats, Dogs, Wild, Tame In Vanguard Of Cracking Nature's SARS Virus Reservoir
Read More
Alnylam Signs Deal; Sirna Gets License In Young RNAi Space
Read More
Correction
Read More
Therion Raises $39M To Expand Operations For Vaccine Products
Read More
Other News To Note
Read More